Ignite Creation Date:
2025-12-24 @ 1:13 PM
Ignite Modification Date:
2026-02-23 @ 10:36 PM
Study NCT ID:
NCT02559895
Status:
COMPLETED
Last Update Posted:
2020-05-14
First Post:
2015-09-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
Sponsor:
Alder Biopharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ALD403-CLIN-006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None